文献速递妇科

卵巢囊肿液结合珠蛋白作为上皮性卵巢癌潜在即时检验的诊断准确性:一项观察性研究

Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study.
PubMed 文献 · BJOG · 2017-09-04

本研究在东南亚纳入可疑卵巢囊肿女性,用蛋白质组学、免疫组化和ELISA检测囊肿液结合珠蛋白,并与CA125、风险恶性指数及冰冻切片比较,结合珠蛋白对上皮性卵巢癌诊断性能优于CA125和风险恶性指数,盲法验证的即时检验装置灵敏度85.2%、特异度90.5%。

要点

  • 卵巢囊肿液结合珠蛋白在良性囊肿为0.70±0.09 mg/ml,早期上皮性卵巢癌为6.22±0.53 mg/ml,晚期为6.57±0.65 mg/ml。
  • 结合珠蛋白AUROC为0.999(95%CI 0.997-1.000),CA125为0.895(95%CI 0.814-0.977),两者差异P<0.05。
  • 盲法验证中即时检验装置平均诊断性能略降,灵敏度85.2%、特异度90.5%。

核心结论

  • 结合珠蛋白被识别为检测上皮性卵巢癌的生物标志物,具有作为即时诊断工具的潜力。

研究设计与样本

  • 回顾性和前瞻性队列研究,地点为东南亚,对象为可疑卵巢囊肿的女性。
  • 采用蛋白质组学、免疫组织化学和ELISA法测量卵巢囊肿液中的结合珠蛋白,以区分良性和上皮性卵巢癌。
  • 将结合珠蛋白的诊断性能与CA125、风险恶性指数和冰冻切片进行比较,并对即时检验装置进行盲法验证。

主要发现

  • ELISA测定的结合珠蛋白浓度:良性囊肿患者(n=87)为0.70±0.09 mg/ml,早期上皮性卵巢癌(n=17)为6.22±0.53 mg/ml,晚期上皮性卵巢癌(n=20)为6.57±0.65 mg/ml。
  • 上皮性卵巢癌中的结合珠蛋白显著高于良性囊肿(P<0.0001)。
  • 在训练集上使用快速比色法检测结合珠蛋白的灵敏度为97.3%,特异度为92.0%,与ELISA和冰冻切片相当。
  • 结合珠蛋白的AUROC曲线为0.999(95%CI 0.997-1.000),CA125为0.895(95%CI 0.814-0.977),差异P<0.05。
  • 结合珠蛋白显著优于所有风险恶性指数(P<0.01)。

临床怎么用

  • 作者认为卵巢囊肿液结合珠蛋白有潜力作为上皮性卵巢癌的即时诊断工具。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate haptoglobin within ovarian cyst fluid (OCF) as a diagnostic biomarker for epithelial ovarian cancer (EOC) and develop an in vitro diagnostic point-of-care device test (IVDPCT) for use in the operating theatre. DESIGN: Retrospective and prospective cohort study. SETTING: South-East Asia. POPULATION: Women with suspicious ovarian cysts. METHODS: Proteomic, immunohistochemical and ELISA methods measured haptoglobin in OCF to differentiate benign and EOCs. Diagnostic performance of haptoglobin was compared with CA125, risk malignancy indices (RMI) and frozen section. Blinded validation of the IVDPCT was performed. MAIN OUTCOME MEASURES: Prediction of malignancy. RESULTS: Haptoglobin concentration measured by ELISA was 0.70 ± 0.09 mg/ml in patients with benign cysts (n = 87), 6.22 ± 0.53 mg/ml in early stage-EOC (n = 17), and 6.57 ± 0.65 mg/ml in late stage-EOC (n = 20). Haptoglobin in EOCs was significantly higher than in benign cysts (P < 0.0001). Haptoglobin using rapid colorimetric assay (RCA) on a training set had a sensitivity of 97.3% and a specificity 92.0%, comparable to ELISA and frozen sections. The haptoglobin AUROC curve was 0.999 (95% CI 0.997-1.000) compared with 0.895 (95% CI 0.814-0.977, P < 0.05) for CA125. Haptoglobin performed significantly better than all the RMIs (P < 0.01). Blinded validation studies showed a minor drop in average diagnostic performance (sensitivity 85.2% and specificity 90.5%) compared with the training set. However, when compared with frozen section, haptoglobin was no worse in diagnostic accuracy for malignancy. CONCLUSION: Haptoglobin was identified as a biomarker for the detection of EOC with potential as a point-of-care diagnostic tool. TWEETABLE ABSTRACT: Haptoglobin within ovarian cyst fluid: a biomarker for epithelial ovarian cancer and point-of-care diagnostics.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Mahyuddin AP, Liu L, Zhao C, et al. Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study. BJOG. 2017. PMID: 28755436. doi:10.1111/1471-0528.14835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。